Publications
Books 3
Adekola, T.A (2023)[cite: 69]
Regional Cooperation, Intellectual Property Law and Access to Medicines: A Holistic Approach for Least Developed Countries.[cite: 69]
London, United Kingdom: Routledge.[cite: 70]
Read Book [cite: 70]
Reviewed by Chimdessa Fekadu Tsega (2024)[cite: 71]
The case for a holistic approach to IP law and access to medicines for least developed countries: an African perspective[cite: 71]
Journal of Intellectual Property Law & Practice, Vol 19, Issue 8, Pages 690–691.[cite: 71, 72]
Read Review [cite: 72]
P Omkar Nadh and Tolulope A Adekola (eds) (2026)[cite: 73]
Socio-Technological Relationships in Vaccine Systems: Uncovering the Dynamics of Interaction[cite: 73]
Palgrave Macmillan, 1st ed, 2026.[cite: 73]
Upcoming Release
Book Chapters 3
Adekola, T. (2026)[cite: 75]
Socio-Technological Relationships in Vaccine Systems: Innovation, Production, Distribution, and Equity[cite: 75]
In: Socio-Technological Relationships in Vaccine Systems (Palgrave Macmillan)[cite: 75]
Adekola, T. (2026)[cite: 76]
Vaccine Technology Platforms, Market Structures, Intellectual Property Regimes, and Local Production[cite: 76]
In: Socio-Technological Relationships in Vaccine Systems (Palgrave Macmillan)[cite: 76]
Adekola, T. (2024)[cite: 77]
Intellectual Property and Local Pharmaceutical Production: Defining the Need and Meeting the Challenge.[cite: 77]
In: Contemporary Issues in Intellectual Property Law in Africa (pp. 84-102). Routledge.[cite: 78]
Journal Articles 19
Adekola, T. A. (2026)[cite: 80]
Whose Knowledge, Whose Cure? Traditional Medicine and the boundaries of WIPO's 2024 Genetic Resources Treaty.[cite: 80]
The Journal of World Intellectual Property, 1–22.[cite: 80]
Read Article [cite: 81]
Adekola, T. A., & Mercurio, B. (2025)[cite: 82]
mRNA Technology transfer hub and intellectual property: Towards a more equitable and sustainable model.[cite: 82]
World Trade Review, 24 (2), 302-320.[cite: 83]
Adekola, T.A & Kunle Ola (2025)[cite: 84]
Intellectual Property and Rare Diseases: Addressing Market Failures Through Strategic Frameworks[cite: 84]
European Intellectual Property Review 47(4)[cite: 84]
Adekola, Tolulope Anthony et al. (2024)[cite: 85]
Regulating Genome-Edited Products – an International Trade Law Perspective[cite: 85]
Max Planck Institute for Innovation & Competition Research Paper No. 24-13.[cite: 86]
Adekola, T. A., & Majekolagbe, F. O. (2023)[cite: 87]
Human rights law, intellectual property and vaccine nationalism: lessons for the post-COVID-19 world.[cite: 87]
Australian Journal of Human Rights, 1-19.[cite: 88]
Read Article [cite: 88]
Adekola, T. A. (2023)[cite: 89]
When mRNA technology meets patent law: innovation, barriers and public health.[cite: 89]
Journal of Intellectual Property Law and Practice, 18(12), 867-877.[cite: 90]
Mercurio, B., Adekola, T.A. and Tsega, C.F. (2023)[cite: 91]
Pharmaceutical patent law and policy in Africa: a survey of selected SADC member states.[cite: 92]
Legal Studies, pp.1-20.[cite: 92]
SSCI Indexed[cite: 93]
Adekola, T.A. (2022)[cite: 94]
Compulsory licences in a regional context: an appraisal of the TRIPS amendment’s special regional treatment.[cite: 94]
GRUR International, 71(9), pp.822-830.[cite: 95]
Adekola, T.A. (2020)[cite: 96]
Should COVID-19 treatment be patented? Rethinking the theoretical justification for the grant of pharmaceutical patent.[cite: 96]
European Intellectual Property Review, 42(11), pp.695-697.[cite: 97]
Adekola, T.A (2020)[cite: 98]
Regional mechanism under Doha paragraph 6 system-The largely untested alternative route for access to patented medicines.[cite: 98]
Asian J. WTO & Int'l Health L & Pol'y 15: 61.[cite: 99]
SSCI Indexed[cite: 99]
Adekola, T.A. (2020)[cite: 100]
Revisiting the public health implications of the United States–Mexico–Canada agreement.[cite: 100]
Globalization and Health, 16(1), p.50.[cite: 101]
SSCI Indexed[cite: 101]
Adekola, T.A. (2020)[cite: 102]
Book review: Intellectual Property and Access to Medicines in Africa: A Regional Framework for Access (Olasupo Owoeye)[cite: 102]
Queen Mary Journal of Intellectual Property, 10(2), pp.269-270.[cite: 102]
SSCI Indexed[cite: 103]
Xiao, S. and Adekola, T.A. (2021)[cite: 104]
Investment Robo-Advisors: Some Reflections on China's Regulatory Experience.[cite: 104]
Banking & Finance Law Review, 37(1), pp.127-148.[cite: 105]
Adekola, T.A. (2019)[cite: 106]
US–China trade war and the WTO dispute settlement mechanism.[cite: 106]
Journal of International Trade Law and Policy, 18(3), pp.125-135.[cite: 107]
Adekola, T.A. (2019)[cite: 108]
Abolition of graphical representation in EU trademark directive: Should countries with similar provisions follow EU’s footsteps?[cite: 108]
Journal of Intellectual Property Rights, 24(3-4), pp.62-68.[cite: 109]
Adekola, T.A. (2019)[cite: 110]
Public health–oriented intellectual property and trade policies in Africa and the regional mechanism under TRIPS amendment.[cite: 110]
Public Health, 173, pp.1-4.[cite: 111]
Eze, S.C., Bello, A.O. and Adekola, T.A. (2017)[cite: 112]
The effects of organizational structure on the performance of organizations.[cite: 112]
European Journal of Business and Innovation Research, 5(6), pp.46-62.[cite: 113]
Adekola T.A (2023)[cite: 114]
Are TRIPS flexibilities fully leveraged for pharmaceutical access in Africa?[cite: 114]
Published on Medium[cite: 114]
Read Article [cite: 114]
Adekola T.A (2022)[cite: 115]
In search of a suitable theoretical justification for patent rights[cite: 115]
Published by Afronomics.[cite: 115]
Read Article [cite: 115]